Keywords: revenues, decline, up, scios, biopharmaceutical, company, inc
REVENUES DECLINE, R&D UP AT SCIOS IN 1991
Article | 04 May 1992
The US biopharmaceutical company Scios Inc, which was formerly known as California Biotechnol-ogy, saw total revenues decline around 40% in 1991 to $7.4 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- US Supreme Court says patent settlement can "sometimes" be illegal
- Negative US patent ruling for Novo Nordisk on Prandin
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
